Article Type
Changed
Display Headline
Adenotonsillectomy for OSAS led to weight gain, even in overweight children

Adenotonsillectomy for obstructive sleep apnea syndrome led to clinically significant weight gain, even in children who were overweight at baseline, according to a first-in-kind randomized clinical trial published in the August issue of Pediatrics.

More than 52% of overweight children with obstructive sleep apnea syndrome (OSAS) who underwent adenotonsillectomy developed obesity within 7 months, compared with 21% of those randomized to watchful waiting and supportive care (P less than .05), reported Dr. Eliot S. Katz of Boston Children’s Hospital and his associates.

Based on those results, children who undergo adenotonsillectomy for OSAS should be monitored for weight changes, receive nutritional counseling, and be encouraged to exercise, the researchers said (Pediatrics 2014;134:282-9).

For the multicenter, single-blind clinical trial, the investigators randomized 464 children aged 5-9.9 years with OSAS to undergo either early adenotonsillectomy – defined as surgery within 4 weeks of randomization – or watchful waiting and supportive care.

Children classified as failing to thrive at baseline were more likely to attain a normal weight after adenotonsillectomy, compared with watchful waiting, although the difference was not statistically significant, Dr. Katz and his associates said.

The National Institutes of Health funded the study. One coauthor reported having served as a consultant for Zansors and receiving grants from Respironics/Phillips and Fisher-Paykel. The other authors reported no conflicts of interest.

References

Click for Credit Link
Author and Disclosure Information

Publications
Topics
Legacy Keywords
Adenotonsillectomy, obstructive sleep apnea, weight gain, OSAS, obesity, Dr. Eliot S. Katz,
Sections
Click for Credit Link
Click for Credit Link
Author and Disclosure Information

Author and Disclosure Information

Adenotonsillectomy for obstructive sleep apnea syndrome led to clinically significant weight gain, even in children who were overweight at baseline, according to a first-in-kind randomized clinical trial published in the August issue of Pediatrics.

More than 52% of overweight children with obstructive sleep apnea syndrome (OSAS) who underwent adenotonsillectomy developed obesity within 7 months, compared with 21% of those randomized to watchful waiting and supportive care (P less than .05), reported Dr. Eliot S. Katz of Boston Children’s Hospital and his associates.

Based on those results, children who undergo adenotonsillectomy for OSAS should be monitored for weight changes, receive nutritional counseling, and be encouraged to exercise, the researchers said (Pediatrics 2014;134:282-9).

For the multicenter, single-blind clinical trial, the investigators randomized 464 children aged 5-9.9 years with OSAS to undergo either early adenotonsillectomy – defined as surgery within 4 weeks of randomization – or watchful waiting and supportive care.

Children classified as failing to thrive at baseline were more likely to attain a normal weight after adenotonsillectomy, compared with watchful waiting, although the difference was not statistically significant, Dr. Katz and his associates said.

The National Institutes of Health funded the study. One coauthor reported having served as a consultant for Zansors and receiving grants from Respironics/Phillips and Fisher-Paykel. The other authors reported no conflicts of interest.

Adenotonsillectomy for obstructive sleep apnea syndrome led to clinically significant weight gain, even in children who were overweight at baseline, according to a first-in-kind randomized clinical trial published in the August issue of Pediatrics.

More than 52% of overweight children with obstructive sleep apnea syndrome (OSAS) who underwent adenotonsillectomy developed obesity within 7 months, compared with 21% of those randomized to watchful waiting and supportive care (P less than .05), reported Dr. Eliot S. Katz of Boston Children’s Hospital and his associates.

Based on those results, children who undergo adenotonsillectomy for OSAS should be monitored for weight changes, receive nutritional counseling, and be encouraged to exercise, the researchers said (Pediatrics 2014;134:282-9).

For the multicenter, single-blind clinical trial, the investigators randomized 464 children aged 5-9.9 years with OSAS to undergo either early adenotonsillectomy – defined as surgery within 4 weeks of randomization – or watchful waiting and supportive care.

Children classified as failing to thrive at baseline were more likely to attain a normal weight after adenotonsillectomy, compared with watchful waiting, although the difference was not statistically significant, Dr. Katz and his associates said.

The National Institutes of Health funded the study. One coauthor reported having served as a consultant for Zansors and receiving grants from Respironics/Phillips and Fisher-Paykel. The other authors reported no conflicts of interest.

References

References

Publications
Publications
Topics
Article Type
Display Headline
Adenotonsillectomy for OSAS led to weight gain, even in overweight children
Display Headline
Adenotonsillectomy for OSAS led to weight gain, even in overweight children
Legacy Keywords
Adenotonsillectomy, obstructive sleep apnea, weight gain, OSAS, obesity, Dr. Eliot S. Katz,
Legacy Keywords
Adenotonsillectomy, obstructive sleep apnea, weight gain, OSAS, obesity, Dr. Eliot S. Katz,
Sections
Article Source

FROM PEDIATRICS

PURLs Copyright

Inside the Article

Vitals

Key clinical point: Adenotonsillectomy for obstructive sleep apnea syndrome increases the risk of obesity in overweight children.

Major finding: Almost 52% of overweight children randomized to adenotonsillectomy developed obesity in the subsequent 7 months, compared with 21% of overweight children in the control group (P less than .05).

Data source: Multicenter, single-blind, clinical trial of 464 children with OSAS randomized either to early adenotonsillectomy or watchful waiting and supportive care.

Disclosures: The National Institutes of Health funded the study. One coauthor reported having served as a consultant for Zansors and receiving grants from Respironics/Phillips and Fisher-Paykel. The other authors reported no conflicts of interest.